Stocks opened the first week of December with significant losses, driven by some emerging concerns of exaggerated rate cut spec...

Kicking off the new month, Wall Street continued its strong November momentum, with major U.S. stocks rallying on Friday.

Thursday’s trading session on Wall Street presents a mixed picture, characterized by notable fluctuations in major indices. Whi...

Stocks are experiencing their 16th green session out of the 20 so far in November, with the S&P 500 index reaching its high...

U.S. stocks experienced a welcome resurgence on Tuesday, buoyed by the latest comments from Federal Reserve officials.

Roivant stock has outperformed the broader market and the biotech sector this year, mirroring the rise in the fortunes of its f...

We performed a screening of mid-cap ETFs - defined as having Assets Under Management (AUM) between $2 billion and $10 billion -...

It's a good time to look at how the major U.S. stock industry ETFs performed this month, as April comes to an end. In April...

Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. T...

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named SPDR S&P Biotech...

U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeki...